Wyoming, MI
Linked In
You Tube
University of Michigan Health-West
Trials at this location:
HCRN-BRE20-468
A Phase II Study of Ribociclib And Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)
Status: Open to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter